RESUMEN
The Indiana kindred variant of Gerstmann-Sträussler-Scheinker disease has amyloid plaques that contain prion protein (PrP), but is atypical because neurofibrillary tangles like those of Alzheimer disease are present. To map the position of the disease causing gene, we used three markers for linkage analyses. A missense mutation at codon 198 of the PrP gene (PRNP) is found in all definitely affected individuals and yields a maximum lod score of 6.37 (theta = 0). The disease also is concordant with the two other PRNP-region markers. These results demonstrate tight linkage of the disease-causing gene to PRNP and support the hypothesis that the codon 198 mutation is the cause of IK-GSS. Our studies also suggest that methionine/valine heterozygotes at PRNP codon 129 have a later age of onset of the disease than codon 129 valine/valine homozygotes.
Asunto(s)
Ligamiento Genético , Enfermedad de Gerstmann-Straussler-Scheinker/genética , Priones/genética , Adulto , Factores de Edad , Anciano , Secuencia de Aminoácidos , Secuencia de Bases , ADN/genética , Femenino , Marcadores Genéticos , Humanos , Indiana , Masculino , Persona de Mediana Edad , Datos de Secuencia Molecular , Linaje , Mutación Puntual , Proteínas PrPScRESUMEN
Two families with Gerstmann-Sträussler-Scheinker disease (GSS) are atypical in possessing neocortical neurofibrillary tangles (NFTs), which are few or absent in other kindreds with GSS, in addition to amyloid plaques that react with prion protein (PrP) antibodies and protease-resistant PrP accumulation in the brain. A leucine substitution at PrP codon 102 has been genetically linked to GSS in some families. We examined the PrP gene in these families. A serine for phenylalanine substitution was found at codon 198 in the Indiana patients; arginine for glutamine substitution at codon 217 in the Swedish patients. These mutations in PrP are the first to be associated with the appearance of both PrP amyloid plaques and neocortical NFTs in GSS patients.
Asunto(s)
Enfermedad de Gerstmann-Straussler-Scheinker/genética , Ovillos Neurofibrilares/patología , Priones/genética , Adulto , Anciano , Secuencia de Aminoácidos , Secuencia de Bases , ADN/genética , Femenino , Enfermedad de Gerstmann-Straussler-Scheinker/patología , Humanos , Masculino , Persona de Mediana Edad , Datos de Secuencia Molecular , Mutación Puntual , Proteínas PrPScRESUMEN
Alternative products of the proteolipid protein gene (PLP), proteolipid protein (PLP) and DM20, are major components of compact myelin in the central nervous system, but quantitatively minor constituents of Schwann cells. A family with a null allele of PLP has a less severe CNS phenotype than those with other types of PLP mutations. Moreover, individuals with PLP null mutations have a demyelinating peripheral neuropathy, not seen with other PLP mutations of humans or animals. Direct analysis of normal peripheral nerve demonstrates that PLP is localized to compact myelin. This and the clinical and pathologic observations of the PLP null phenotype indicate that PLP/DM20 is necessary for proper myelin function both in the central and peripheral nervous systems.
Asunto(s)
Sistema Nervioso Central/metabolismo , Corteza Cerebral/patología , Enfermedades Desmielinizantes/genética , Proteínas de la Mielina/metabolismo , Proteína Proteolipídica de la Mielina/genética , Sistema Nervioso Periférico/metabolismo , Adolescente , Adulto , Niño , Preescolar , Enfermedades Desmielinizantes/metabolismo , Humanos , Imagen por Resonancia Magnética , Persona de Mediana Edad , Proteínas de la Mielina/fisiología , Proteína Proteolipídica de la Mielina/fisiología , LinajeRESUMEN
We demonstrate that the previously described gene Androgen binding protein (Abp; Dlouhy and Karn, 1984) codes for the Alpha subunit of ABP and rename the locus Androgen binding protein alpha (Abpa). A study of recombinant inbred strains demonstrates that Abpa is located on chromosome 7 near Glucose phosphate isomerase-1 (Gpi-1). Biochemical and genetic evidence indicates the existence of another ABP subunit, Gamma, and its locus, Androgen binding protein gamma (Abpg), that is closely linked to Abpa. Although no polymorphism has yet been found for the previously described Beta subunit of ABP (Dlouhy and Karn, 1983; 1984), we suggest that it represents a third locus. Androgen binding protein beta (Abpb). ABP subunits appear to dimerize randomly and a model is presented demonstrating the origin of six ABP dimers in the salivas of AbpaaAbpga/AbpabAbpgb heterozygous mice. The results of cell-free translation studies in which the pre-ABP subunits are identified specifically by immunoprecipitation with anti-ABP antibody supports the idea that independent mRNAs code for the Alpha, Beta and Gamma subunits.
Asunto(s)
Proteína de Unión a Andrógenos/genética , Genes , Animales , Mapeo Cromosómico , Cruzamientos Genéticos , Femenino , Sustancias Macromoleculares , Masculino , Ratones , Ratones Endogámicos , Biosíntesis de Proteínas , Saliva/metabolismo , Especificidad de la Especie , Glándula Submandibular/metabolismoRESUMEN
A mutation in the gene Girk2 that encodes an inwardly rectifying potassium channel is the genetic defect causing the behavioral and pathologic abnormalities of the weaver mutant mouse. Of the pathologic abnormalities, the best studied is the neuronal degeneration that occurs in the cerebellar cortex and in the midbrain dopaminergic neurons. A detailed characterization of the topographic and temporal expression of Girk2 is fundamental to elucidate the mechanisms underlying neurodegeneration in these mutant mice. In this study we utilized in situ hybridization to determine the expression of Girk2 mRNA during prenatal and postnatal development in the murine central nervous system (CNS). Girk2 expression was seen in multiple regions of embryonic CNS including the cerebellum and midbrain. During postnatal development, the highest expression was seen in the cerebellum, midbrain and hippocampus. However, since the developing cerebellum undergoes significant neuronal loss due to the degeneration of granule cell precursors, Girk2 mRNA expression in this area decreases progressively.
Asunto(s)
Sistema Nervioso Central/embriología , Sistema Nervioso Central/crecimiento & desarrollo , Expresión Génica/genética , Degeneración Nerviosa/genética , Canales de Potasio de Rectificación Interna , Canales de Potasio/genética , Animales , Canales de Potasio Rectificados Internamente Asociados a la Proteína G , Hibridación in Situ , Ratones , Ratones Mutantes , Ratones Mutantes Neurológicos , ARN Mensajero/genéticaRESUMEN
Gerstmann-Sträussler-Scheinker (GSS) disease is a familial neurological disorder pathologically characterized by accumulation of prion protein (PrP) in the form of fibrillary and non-fibrillary deposits within the cerebrum and cerebellum. We have studied two patients in whom the disease is caused by a leucine for proline amino acid substitution at residue 102 of PrP. In both patients, the neuropathologic findings are similar, consisting of spongiform changes, amyloid deposits, and gliosis. To investigate the antigenic profile of PrP deposits, we used antibodies raised against several peptides that correspond to segments of the N-terminus, repeat region, midregion, and C-terminus of PrP. By immunohistochemistry, PrP amyloid cores are best labeled by antibodies directed to epitopes spanning PrP residues 90-165. In GSS disease caused by a substitution of thymine to cytosine at PRNP codon 198 (Indiana kindred), the major amyloidogenic peptide spans residues 58-150; therefore, in these two genetic forms of GSS disease, amyloid may be composed of different peptides.
Asunto(s)
Amiloide/metabolismo , Anticuerpos/inmunología , Corteza Cerebral/patología , Enfermedad de Gerstmann-Straussler-Scheinker/diagnóstico , Enfermedad de Gerstmann-Straussler-Scheinker/patología , Adulto , Epítopos/inmunología , Humanos , Inmunohistoquímica , Masculino , Persona de Mediana Edad , PrionesRESUMEN
Gerstmann-Sträussler-Scheinker (GSS) disease is a cerebral prion protein (PrP) amyloidosis associated with mutations in the PrP gene (PRNP). A GSS disease variant with mutation at codon 198 (F198S) has been studied in a large Indiana kindred. Biochemical investigations showed that the amyloid protein consists of 11 and 7 kDa fragments of PrP. Immunohistochemical studies showed that in addition to amyloid, these patients accumulate PrP deposits which are neither fluorescent nor birefringent when stained with thioflavin S and Congo red. In the present paper, we analyzed proteinase-K (PK)-resistant PrP in 7 patients with GSS F198S disease. Immunoblots of PK-treated brain extracts show prominent bands of ca. 27-29, 18-19, and 8 kDa. Immunohistochemistry and thioflavin-S-fluorescence show that the amyloid deposits are conspicuous in the cerebellum but sparse in the caudate nucleus. However, immunoblot analysis reveals PK-resistant PrP bands of similar intensity in both regions. Treatment with PK and PNGase F generates a pattern similar to that of PK alone. Our findings suggest that brain extracts from GSS F198S disease contain 3 prominent nonglycosylated PK-resistant PrP fragments forming a pattern not previously described in other prion diseases, which may in part explain the pathology of this GSS disease variant.
Asunto(s)
Endopeptidasa K/farmacología , Enfermedad de Gerstmann-Straussler-Scheinker/metabolismo , Priones/efectos de los fármacos , Priones/metabolismo , Adulto , Anciano , Amiloide/metabolismo , Encéfalo/metabolismo , Encéfalo/patología , Síndrome de Creutzfeldt-Jakob/metabolismo , Síndrome de Creutzfeldt-Jakob/patología , Resistencia a Medicamentos , Enfermedad de Gerstmann-Straussler-Scheinker/genética , Enfermedad de Gerstmann-Straussler-Scheinker/patología , Humanos , Immunoblotting , Isomerismo , Persona de Mediana Edad , Fracciones Subcelulares/metabolismoRESUMEN
Gerstmann-Sträussler-Scheinker disease (GSS), a cerebello-pyramidal syndrome associated with dementia and caused by mutations in the prion protein gene (PRNP), is phenotypically heterogeneous. The molecular mechanisms responsible for such heterogeneity are unknown. Since we hypothesize that prion protein (PrP) heterogeneity may be associated with clinico-pathologic heterogeneity, the aim of this study was to analyze PrP in several GSS variants. Among the pathologic phenotypes of GSS, we recognize those without and with marked spongiform degeneration. In the latter (i.e. a subset of GSS P102L patients) we observed 3 major proteinase-K resistant PrP (PrPres) isoforms of ca. 21-30 kDa, similar to those seen in Creutzfeldt-Jakob disease. In contrast, the 21-30 kDa isoforms were not prominent in GSS variants without spongiform changes, including GSS A117V, GSS D202N, GSS Q212P, GSS Q217R, and 2 cases of GSS P102L. This suggests that spongiform changes in GSS are related to the presence of high levels of these distinct 21-30 kDa isoforms. Variable amounts of smaller, distinct PrPres isoforms of ca. 7-15 kDa were seen in all GSS variants. This suggests that GSS is characterized by the presence PrP isoforms that can be partially cleaved to low molecular weight PrPres peptides.
Asunto(s)
Enfermedad de Gerstmann-Straussler-Scheinker/genética , Enfermedad de Gerstmann-Straussler-Scheinker/metabolismo , Priones/genética , Priones/metabolismo , Adulto , Anciano , Western Blotting , Encéfalo/patología , Química Encefálica , ADN/análisis , ADN/genética , Femenino , Enfermedad de Gerstmann-Straussler-Scheinker/patología , Humanos , Masculino , Persona de Mediana Edad , Peso Molecular , FenotipoRESUMEN
Gerstmann-Sträussler-Scheinker disease is an autosomal dominant disorder with a wide spectrum of clinical presentations including ataxia, spastic paraparesis, extrapyramidal signs, and dementia. The patients present with symptoms in the third to sixth decade of life and the mean duration of illness is five years. Mutations at codons 102, 105, 117, 145, 198 and 217 of the open reading frame of the prion protein gene have been associated with GSS disease. As a result of the mutations, a substitution at the corresponding residues of the prion protein occurs, or as in the case of the STOP mutation at codon 145, a truncated protein is produced. Neuropathologically, the common denominator is a cerebral prion protein amyloidosis; however, there is significant variability in the pattern of amyloid deposition in regions of the central nervous system among reported families. Amyloidosis coexists with severe spongiform degeneration in patients with the mutation at codon 102, and with neurofibrillary degeneration in the patients with mutation at codons 145, 198 and 217. The development of a transmissible spongiform encephalopathy in animals inoculated with brain tissue from affected subjects with mutation at codon 102 suggests that in some forms of genetically-determined Gerstmann-Sträussler-Scheinker disease, and particularly those characterized by severe spongiosis, amyloidogenesis and production of an infectious "agent" occur concomitantly via mechanisms that are only partially understood.
Asunto(s)
Amiloide/química , Enfermedad de Gerstmann-Straussler-Scheinker/genética , Priones/genética , Amiloide/genética , Animales , Encéfalo/patología , Química Encefálica , Codón , Cricetinae , Enfermedad de Gerstmann-Straussler-Scheinker/metabolismo , Enfermedad de Gerstmann-Straussler-Scheinker/patología , Humanos , Inmunohistoquímica , Ratones , Datos de Secuencia Molecular , Ovillos Neurofibrilares/ultraestructura , Mutación Puntual , Priones/análisis , Priones/químicaRESUMEN
The prion protein (PrP) plays an essential role in the pathogenesis of a group of sporadic, genetically determined and infectious fatal degenerative diseases, referred to as "prion diseases", affecting the central nervous system of humans and other mammals. The cellular PrP is encoded by a single copy gene, highly conserved across mammalian species. In prion diseases, PrP undergoes conformational changes involving a shift from alpha-helix to beta-sheet structure. This conversion is important for PrP amyloidogenesis, which occurs to the highest degree in the genetically determined Gerstmann-Sträussler-Scheinker disease (GSS) and prion protein cerebral amyloid angiopathy (PrP-CAA), while it is less frequently seen in other prion diseases. GSS and PrP-CAA are associated with point mutations of the prion protein gene (PRNP); these conditions show a broad spectrum of clinical presentation, the main signs being ataxia, spastic paraparesis, extrapyramidal signs and dementia. In GSS, parenchymal amyloid may be associated with spongiform changes or neurofibrillary lesions; in PrP-CAA, vascular amyloid is associated with neurofibrillary lesions. A major component of the amyloid fibrils in the two diseases is a 7 kDa peptide, spanning residues 81-150 of PrP.
Asunto(s)
Amiloidosis/patología , Encefalopatías/genética , Encéfalo/patología , Enfermedad de Gerstmann-Straussler-Scheinker/genética , Enfermedades por Prión/patología , Priones/química , Priones/genética , Secuencia de Aminoácidos , Amiloidosis/genética , Animales , Secuencia de Bases , Encefalopatías/patología , Codón , Secuencia Conservada , Femenino , Genotipo , Enfermedad de Gerstmann-Straussler-Scheinker/patología , Humanos , Masculino , Mamíferos , Linaje , Mutación Puntual , Enfermedades por Prión/genética , Estructura Secundaria de Proteína , Scrapie/genética , Scrapie/patologíaRESUMEN
Patients affected with Gerstmann-Sträussler-Scheinker disease from two families, one from Indiana and one of Swedish origin, have been studied. The patients are clinically characterized by cerebellar ataxia, extrapyramidal signs, and dementia. Accumulation of amyloid deposits and neurofibrillary tangles are the most conspicuous neuropathologic features. In the patients from the Indiana family, the amyloid contains an 11-kDa peptide, an amyloidogenic degradation product of the prion protein. The neurofibrillary tangles are composed of paired helical filaments and immunoreact with antibody to A68, an abnormally phosphorylated form of the microtubule-associated protein tau. In these families, the disease is caused by a point mutation in the PRNP gene. In the Indiana family, the mutation is at codon 198, and in the Swedish family at codon 217.
Asunto(s)
Enfermedad de Gerstmann-Straussler-Scheinker/genética , Ovillos Neurofibrilares , Mutación Puntual , Priones/genética , Precursores de Proteínas/genética , Anciano , Amiloide/análisis , Animales , Cricetinae , Femenino , Enfermedad de Gerstmann-Straussler-Scheinker/patología , Humanos , Inmunohistoquímica , Indiana , Masculino , Microscopía Electrónica , Persona de Mediana Edad , Proteínas PrPC , Priones/inmunología , Priones/metabolismo , Precursores de Proteínas/inmunología , Precursores de Proteínas/metabolismo , Suecia , Proteínas tau/análisisRESUMEN
The weaver mutation in mice has recently been identified as a single base-pair mutation in the Girk2 gene, which encodes a G-protein-activated inwardly rectifying potassium channel, GIRK2. The mutation results in a Gly to Ser substitution at residue 156, in the putative pore-forming region of the potassium channel. In the present study, we used Xenopus oocytes to express mutant GIRK2, and to characterize the effects of the mutation on the channel. The mutation results in a loss of the normal high selectivity for K+ over Na+, with little effect on other channel properties such as activation by the mu opioid receptor. The resulting increase in basal Na+ permeability causes a marked depolarization of oocytes expressing the mutant GIRK2 protein. This result was observed even when the mutant GIRK2 was coexpressed with GIRK1, a situation more analogous to that seen in vivo. Thus, the increased Na+ permeability and resulting depolarization may contribute to the pathology of cerebellar granule cells and substantia nigra dopaminergic neurons observed in the weaver mice.
Asunto(s)
Oocitos/fisiología , Mutación Puntual , Canales de Potasio de Rectificación Interna , Canales de Potasio/genética , Canales de Potasio/fisiología , Receptores Opioides/fisiología , Analgésicos/farmacología , Animales , Clonación Molecular , Encefalina Ala(2)-MeFe(4)-Gli(5) , Encefalinas/farmacología , Femenino , Canales de Potasio Rectificados Internamente Asociados a la Proteína G , Potenciales de la Membrana/efectos de los fármacos , Ratones , Ratones Mutantes Neurológicos , Microinyecciones , Oocitos/efectos de los fármacos , Técnicas de Placa-Clamp , Reacción en Cadena de la Polimerasa , Potasio/metabolismo , Potasio/farmacología , Canales de Potasio/efectos de los fármacos , ARN Mensajero/administración & dosificación , ARN Mensajero/metabolismo , Receptores Opioides/efectos de los fármacos , Proteínas Recombinantes/metabolismo , Sodio/metabolismo , Sodio/farmacología , Xenopus laevisRESUMEN
BACKGROUND: Gerstmann-Sträussler-Scheinker disease is a rare form of prion disease. OBJECTIVE: To determine the prion mutation in a 51-year-old man without a family history of neurologic disease who died from Gerstmann-Sträussler-Scheinker disease. PATIENT AND METHODS: The patient was a 51-year-old man who died after a 9-year illness characterized by dementia and eventually ataxia. Neuropathologic studies were performed, the results of which revealed abundant prion protein-immunopositive amyloid plaques in the cerebellum without spongiform degeneration. RESULTS: Genetic analysis of the prion protein gene showed a novel mutation at codon 131 that caused a valine-for-glycine substitution (G131V) and homozygosity at codon 129 (129M). Proteinase K-resistant prion protein was detected by Western blot analysis. CONCLUSIONS: This is the first mutation described in the short, antiparallel beta-sheet domain of the prion protein. This report highlights the importance of genetic analysis of patients with atypical dementia even in the absence of a family history.
Asunto(s)
Encéfalo/patología , Enfermedad de Gerstmann-Straussler-Scheinker/genética , Priones/genética , Secuencia de Bases , Encéfalo/fisiología , Enfermedad de Gerstmann-Straussler-Scheinker/patología , Enfermedad de Gerstmann-Straussler-Scheinker/fisiopatología , Humanos , Inmunohistoquímica , Masculino , Persona de Mediana Edad , Datos de Secuencia Molecular , Mutación , Priones/análisisRESUMEN
Three generations of a family exhibit a unique syndrome of X-linked ataxia, pyramidal tract signs, and adult-onset dementia. Initial signs, manifested by 2 to 3 years of age, are delayed walking and tremor. During their teens, the patients develop mild but progressive ataxia and pyramidal tract signs. Memory problems in the third decade initiate a progressive dementia, leading to death in the sixth decade. Laboratory investigations failed to disclose a biochemical basis for the syndrome. Preliminary molecular linkage studies have been conducted, and although the specific position of the responsible gene on the X chromosome has not yet been determined, the q26-qter region and much of the p arm are unlikely sites for this gene. The linkage studies are continuing.
Asunto(s)
Ataxia/genética , Demencia/genética , Ligamiento Genético , Cromosoma X , Adolescente , Adulto , Ataxia/patología , Ataxia/fisiopatología , Preescolar , Demencia/patología , Demencia/fisiopatología , Femenino , Genes Recesivos , Humanos , Espectroscopía de Resonancia Magnética , Masculino , Persona de Mediana Edad , Degeneraciones Espinocerebelosas/genéticaRESUMEN
We present the clinical findings in affected members of a large kindred with Gerstmann-Sträussler-Scheinker disease. Sixty-four patients exhibited progressive ataxia, dementia, and parkinsonian features. Inheritance appears to be autosomal dominant. Impaired smooth-pursuit eye movements, defective short-term memory, clumsiness of the hands, and ataxia of gait develop in the late 30s to early 60s. Eye movement abnormalities are characteristic of cerebellar dysfunction. Dementia progresses gradually over several years. Later, rigidity and bradykinesia appear and, at this stage, there is often psychosis or severe depression with rapid weight loss. Death occurs in 6 months to 2 years after onset of rigidity. Magnetic resonance imaging in 2 affected individuals showed cerebellar atrophy. There is decreased T2 signal in the basal ganglia, consistent with iron deposition.
Asunto(s)
Enfermedades por Virus Lento/genética , Adulto , Encéfalo/patología , Demencia/etiología , Depresión/etiología , Electroencefalografía , Femenino , Humanos , Imagen por Resonancia Magnética , Masculino , Trastornos de la Memoria/etiología , Persona de Mediana Edad , Enfermedades Musculares/etiología , Enfermedades del Sistema Nervioso/etiología , Enfermedad de Parkinson Secundaria/etiología , Linaje , Enfermedades por Virus Lento/complicaciones , Enfermedades por Virus Lento/diagnósticoRESUMEN
A 23-year-old man with Pelizaeus-Merzbacher disease had a novel mutation, C344A (Thr115Lys), in exon 3 of the proteolipid protein gene (PLP) His mother, heterozygous for the mutation, developed progressive personality change and a gait disorder in her mid-20s. Her MRI at age 53 showed a diffuse severe leukodystrophy. This report extends the phenotypic range of disease due to PLP gene mutations to include adult-onset dementia in females.
Asunto(s)
Esclerosis Cerebral Difusa de Schilder/genética , Proteolípidos/genética , Adulto , Edad de Inicio , Encéfalo/patología , Esclerosis Cerebral Difusa de Schilder/patología , Femenino , Humanos , Masculino , Persona de Mediana Edad , MutaciónRESUMEN
Azzarelli et al reported an Indiana kindred affected by a hereditary disorder, characterized clinically by ataxia, parkinsonism, and dementia. Recently, we studied neuropathologically the 3rd and 4th cases that came to autopsy among the patients of this family. As in 2 patients examined previously, amyloid plaques were widespread throughout the cerebrum and the cerebellum, whereas neurofibrillary tangles were numerous in the cerebral cortex, the hippocampus, and the substantia innominata. Amyloid plaques were not recognized by polyclonal antibodies against the Alzheimer's disease amyloid A4 protein, but did contain epitopes recognized by antibodies against a prion protein. Spongiform changes were occasionally observed and were mild. Our findings indicate that this familial disorder is a form of or is related to Gerstmann-Sträussler-Scheinker disease. The consistent presence of numerous neurofibrillary tangles may be important in differentiating a distinct subgroup of patients with familial Gerstmann-Sträussler-Scheinker disease, and indicates that a disturbance of the cytoskeleton might be part of the neuronal pathology of Gerstmann-Sträussler-Scheinker disease.
Asunto(s)
Amiloide/metabolismo , Neurofibrillas/patología , Enfermedades por Virus Lento/patología , Proteínas Virales/metabolismo , Encéfalo/metabolismo , Encéfalo/patología , Encéfalo/ultraestructura , Supervivencia Celular , Humanos , Inmunohistoquímica , Masculino , Microscopía Electrónica , Persona de Mediana Edad , Neurofibrillas/ultraestructura , Neuronas/patología , Proteínas PrPSc , Priones/metabolismo , Enfermedades por Virus Lento/metabolismoRESUMEN
BACKGROUND: Insomnia with predominant thalamic involvement and minor cortical and cerebellar pathologic changes is not characteristic of familial Creutzfeldt-Jakob disease (CJD) but is a hallmark of fatal familial insomnia. OBJECTIVE: To report a 53-year-old woman with intractable insomnia as her initial symptom of disease. METHODS: The authors characterized clinical, pathologic, and molecular features of the disease using EEG, polysomnography, neurohistology, Western blotting, protein sequencing, and prion protein (PrP) gene (PRNP) analysis. RESULTS: The patient developed dysgraphia, dysarthria, bulimia, myoclonus, memory loss, visual hallucinations, and opisthotonos, as well as pyramidal, extrapyramidal, and cerebellar signs. Polysomnographic studies showed an absence of stages 3 and 4, and REM. She died 8 months after onset. On neuropathologic examination, there was major thalamic involvement characterized by neuronal loss, spongiform changes, and prominent gliosis. The inferior olivary nuclei exhibited chromatolysis, neuronal loss, and gliosis. Spongiform changes were mild in the neocortex and not evident in the cerebellum. PrP immunopositivity was present in these areas as well as in the thalamus. PRNP analysis showed the haplotype E200K-129M. Western blot analysis showed the presence of proteinase K (PK)-resistant PrP (PrP(sc)) with the nonglycosylated isoform of approximately 21 kd, corresponding in size to that of type 1 PrP(sc). N-terminal protein sequencing demonstrated PK cleavage sites at glycine (G) 82 and G78, as previously reported in CJD with the E200K-129 M haplotype. CONCLUSIONS: Insomnia may be a prominent early symptom in cases of CJD linked to the E200K-129M haplotype in which the thalamus is severely affected.
Asunto(s)
Síndrome de Creutzfeldt-Jakob/complicaciones , Síndrome de Creutzfeldt-Jakob/patología , Trastornos del Inicio y del Mantenimiento del Sueño/etiología , Trastornos del Inicio y del Mantenimiento del Sueño/patología , Tálamo/patología , Secuencia de Aminoácidos , Sustitución de Aminoácidos/genética , Western Blotting , Síndrome de Creutzfeldt-Jakob/genética , Resultado Fatal , Femenino , Humanos , Persona de Mediana Edad , Datos de Secuencia Molecular , Polisomnografía , Priones/análisis , Priones/genética , Privación de Sueño/etiología , Privación de Sueño/genética , Privación de Sueño/patología , Trastornos del Inicio y del Mantenimiento del Sueño/genéticaRESUMEN
By simultaneously amplifying more than one locus in the same reaction, multiplex PCR is becoming a rapid and convenient screening assay in both the clinical and the research laboratory. While numerous papers and manuals discuss in detail conditions influencing the quality of PCR in general, relatively little has been published about the important experimental factors and the common difficulties frequently encountered with multiplex PCR. We have examined various conditions of the multiplex PCR, using a large number of primer pairs. Especially important for a successful multiplex PCR assay are the relative concentrations of the primers at the various loci, the concentration of the PCR buffer, the cycling temperatures and the balance between the magnesium chloride and deoxynucleotide concentrations. Based on our experience, we propose a protocol for developing a multiplex PCR assay and suggest ways to overcome commonly encountered problems.
Asunto(s)
Reacción en Cadena de la Polimerasa/métodos , Tampones (Química) , Cartilla de ADN , Dimetilsulfóxido , Electroforesis en Gel de Agar , Electroforesis en Gel de Poliacrilamida , Glicerol , Indicadores y Reactivos , Cloruro de Magnesio/administración & dosificación , Nucleótidos/administración & dosificación , Albúmina Sérica Bovina , Soluciones , Polimerasa Taq/metabolismo , Temperatura , Moldes Genéticos , Factores de TiempoRESUMEN
X-linked nephrogenic diabetes insipidus (NDI) was segregating in a large Indiana family. It was tested for linkage of the NDI gene to X-chromosome molecular markers. Maximum lod scores of 3.15 and 3.01 (theta = 0) obtained for the molecular markers F8A (F8C) and DXS15 (DX13) respectively, indicate that the NDI gene is located in Xq28. A lod score of 3.61 (theta = 0) was obtained with multipoint linkage analysis of F8A and DXS15.